Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

AWX vs USPH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
AWX
Avalon Holdings Corporation

Waste Management

IndustrialsAMEX • US
Market Cap$10M
5Y Perf.+84.7%
USPH
U.S. Physical Therapy, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$897M
5Y Perf.-20.4%

AWX vs USPH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
AWX logoAWX
USPH logoUSPH
IndustryWaste ManagementMedical - Care Facilities
Market Cap$10M$897M
Revenue (TTM)$85M$695M
Net Income (TTM)$585K$11M
Gross Margin15.3%22.0%
Operating Margin3.7%12.2%
Forward P/E30.7x20.6x
Total Debt$35M$426M
Cash & Equiv.$4M$36M

AWX vs USPHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

AWX
USPH
StockMay 20May 26Return
Avalon Holdings Cor… (AWX)100184.7+84.7%
U.S. Physical Thera… (USPH)10079.6-20.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: AWX vs USPH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: USPH leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Avalon Holdings Corporation is the stronger pick specifically for recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
AWX
Avalon Holdings Corporation
The Long-Run Compounder

AWX is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 29.1% 10Y total return vs USPH's 22.6%
  • Lower volatility, beta -0.12, Low D/E 94.3%, current ratio 1.01x
  • Beta -0.12, current ratio 1.01x
Best for: long-term compounding and sleep-well-at-night
USPH
U.S. Physical Therapy, Inc.
The Income Pick

USPH carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 5 yrs, beta 0.93, yield 3.1%
  • Rev growth 16.3%, EPS growth -22.8%, 3Y rev CAGR 12.2%
  • 16.3% revenue growth vs AWX's -0.3%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthUSPH logoUSPH16.3% revenue growth vs AWX's -0.3%
ValueUSPH logoUSPHLower P/E (20.6x vs 30.7x)
Quality / MarginsUSPH logoUSPH1.5% margin vs AWX's 0.7%
Stability / SafetyUSPH logoUSPHLower D/E ratio (55.3% vs 94.3%)
DividendsUSPH logoUSPH3.1% yield; 5-year raise streak; the other pay no meaningful dividend
Momentum (1Y)AWX logoAWX-7.0% vs USPH's -14.3%
Efficiency (ROA)USPH logoUSPH0.9% ROA vs AWX's 0.7%, ROIC 5.6% vs 2.2%

AWX vs USPH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

AWXAvalon Holdings Corporation
FY 2025
Deferred Membership Dues
78.3%$7M
Customer Advance Deposits
21.7%$2M
USPHU.S. Physical Therapy, Inc.
FY 2025
Net Patient Revenues
83.3%$650M
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues
16.7%$131M

AWX vs USPH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUSPHLAGGINGAWX

Income & Cash Flow (Last 12 Months)

USPH leads this category, winning 4 of 6 comparable metrics.

USPH is the larger business by revenue, generating $695M annually — 8.2x AWX's $85M. Profitability is closely matched — net margins range from 1.5% (USPH) to 0.7% (AWX).

MetricAWX logoAWXAvalon Holdings C…USPH logoUSPHU.S. Physical The…
RevenueTrailing 12 months$85M$695M
EBITDAEarnings before interest/tax$5M$107M
Net IncomeAfter-tax profit$585,000$11M
Free Cash FlowCash after capex$3M$67M
Gross MarginGross profit ÷ Revenue+15.3%+22.0%
Operating MarginEBIT ÷ Revenue+3.7%+12.2%
Net MarginNet income ÷ Revenue+0.7%+1.5%
FCF MarginFCF ÷ Revenue+4.0%+9.6%
Rev. Growth (YoY)Latest quarter vs prior year+9.9%+7.7%
EPS Growth (YoY)Latest quarter vs prior year+15.8%-115.0%
USPH leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

AWX leads this category, winning 5 of 5 comparable metrics.

At 30.7x trailing earnings, AWX trades at a 26% valuation discount to USPH's 41.5x P/E. On an enterprise value basis, AWX's 7.0x EV/EBITDA is more attractive than USPH's 12.5x.

MetricAWX logoAWXAvalon Holdings C…USPH logoUSPHU.S. Physical The…
Market CapShares × price$10M$897M
Enterprise ValueMkt cap + debt − cash$41M$1.3B
Trailing P/EPrice ÷ TTM EPS30.74x41.55x
Forward P/EPrice ÷ next-FY EPS est.20.63x
PEG RatioP/E ÷ EPS growth rate0.35x
EV / EBITDAEnterprise value multiple6.97x12.52x
Price / SalesMarket cap ÷ Revenue0.12x1.15x
Price / BookPrice ÷ Book value/share0.27x1.16x
Price / FCFMarket cap ÷ FCF4.80x14.71x
AWX leads this category, winning 5 of 5 comparable metrics.

Profitability & Efficiency

USPH leads this category, winning 5 of 9 comparable metrics.

AWX delivers a 1.6% return on equity — every $100 of shareholder capital generates $2 in annual profit, vs $1 for USPH. USPH carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to AWX's 0.94x. On the Piotroski fundamental quality scale (0–9), AWX scores 6/9 vs USPH's 5/9, reflecting solid financial health.

MetricAWX logoAWXAvalon Holdings C…USPH logoUSPHU.S. Physical The…
ROE (TTM)Return on equity+1.6%+1.4%
ROA (TTM)Return on assets+0.7%+0.9%
ROICReturn on invested capital+2.2%+5.6%
ROCEReturn on capital employed+2.8%+7.6%
Piotroski ScoreFundamental quality 0–965
Debt / EquityFinancial leverage0.94x0.55x
Net DebtTotal debt minus cash$31M$390M
Cash & Equiv.Liquid assets$4M$36M
Total DebtShort + long-term debt$35M$426M
Interest CoverageEBIT ÷ Interest expense3.09x15.42x
USPH leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

AWX leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in USPH five years ago would be worth $5,664 today (with dividends reinvested), compared to $5,610 for AWX. Over the past 12 months, AWX leads with a -7.0% total return vs USPH's -14.3%. The 3-year compound annual growth rate (CAGR) favors AWX at -1.8% vs USPH's -17.4% — a key indicator of consistent wealth creation.

MetricAWX logoAWXAvalon Holdings C…USPH logoUSPHU.S. Physical The…
YTD ReturnYear-to-date-9.0%-24.6%
1-Year ReturnPast 12 months-7.0%-14.3%
3-Year ReturnCumulative with dividends-5.2%-43.7%
5-Year ReturnCumulative with dividends-43.9%-43.4%
10-Year ReturnCumulative with dividends+29.1%+22.6%
CAGR (3Y)Annualised 3-year return-1.8%-17.4%
AWX leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — AWX and USPH each lead in 1 of 2 comparable metrics.

AWX is the less volatile stock with a -0.12 beta — it tends to amplify market swings less than USPH's 0.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. USPH currently trades 63.1% from its 52-week high vs AWX's 46.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricAWX logoAWXAvalon Holdings C…USPH logoUSPHU.S. Physical The…
Beta (5Y)Sensitivity to S&P 500-0.12x0.93x
52-Week HighHighest price in past year$5.43$93.50
52-Week LowLowest price in past year$2.10$58.55
% of 52W HighCurrent price vs 52-week peak+46.6%+63.1%
RSI (14)Momentum oscillator 0–10049.246.1
Avg Volume (50D)Average daily shares traded5K171K
Evenly matched — AWX and USPH each lead in 1 of 2 comparable metrics.

Analyst Outlook

USPH leads this category, winning 1 of 1 comparable metric.

USPH is the only dividend payer here at 3.06% yield — a key consideration for income-focused portfolios.

MetricAWX logoAWXAvalon Holdings C…USPH logoUSPHU.S. Physical The…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$102.00
# AnalystsCovering analysts12
Dividend YieldAnnual dividend ÷ price+3.1%
Dividend StreakConsecutive years of raises15
Dividend / ShareAnnual DPS$1.80
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.6%
USPH leads this category, winning 1 of 1 comparable metric.
Key Takeaway

USPH leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AWX leads in 2 (Valuation Metrics, Total Returns). 1 tied.

Best OverallU.S. Physical Therapy, Inc. (USPH)Leads 3 of 6 categories
Loading custom metrics...

AWX vs USPH: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is AWX or USPH a better buy right now?

For growth investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger pick with 16. 3% revenue growth year-over-year, versus -0. 3% for Avalon Holdings Corporation (AWX). Avalon Holdings Corporation (AWX) offers the better valuation at 30. 7x trailing P/E, making it the more compelling value choice. Analysts rate U. S. Physical Therapy, Inc. (USPH) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — AWX or USPH?

On trailing P/E, Avalon Holdings Corporation (AWX) is the cheapest at 30.

7x versus U. S. Physical Therapy, Inc. at 41. 5x.

03

Which is the better long-term investment — AWX or USPH?

Over the past 5 years, U.

S. Physical Therapy, Inc. (USPH) delivered a total return of -43. 4%, compared to -43. 9% for Avalon Holdings Corporation (AWX). Over 10 years, the gap is even starker: AWX returned +29. 1% versus USPH's +22. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — AWX or USPH?

By beta (market sensitivity over 5 years), Avalon Holdings Corporation (AWX) is the lower-risk stock at -0.

12β versus U. S. Physical Therapy, Inc. 's 0. 93β — meaning USPH is approximately -873% more volatile than AWX relative to the S&P 500. On balance sheet safety, U. S. Physical Therapy, Inc. (USPH) carries a lower debt/equity ratio of 55% versus 94% for Avalon Holdings Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — AWX or USPH?

By revenue growth (latest reported year), U.

S. Physical Therapy, Inc. (USPH) is pulling ahead at 16. 3% versus -0. 3% for Avalon Holdings Corporation (AWX). On earnings-per-share growth, the picture is similar: U. S. Physical Therapy, Inc. grew EPS -22. 8% year-over-year, compared to -75. 8% for Avalon Holdings Corporation. Over a 3-year CAGR, USPH leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — AWX or USPH?

U.

S. Physical Therapy, Inc. (USPH) is the more profitable company, earning 1. 9% net margin versus 0. 4% for Avalon Holdings Corporation — meaning it keeps 1. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: USPH leads at 10. 3% versus 2. 4% for AWX. At the gross margin level — before operating expenses — USPH leads at 20. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Which pays a better dividend — AWX or USPH?

In this comparison, USPH (3.

1% yield) pays a dividend. AWX does not pay a meaningful dividend and should not be held primarily for income.

08

Is AWX or USPH better for a retirement portfolio?

For long-horizon retirement investors, Avalon Holdings Corporation (AWX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

12)). Both have compounded well over 10 years (AWX: +29. 1%, USPH: +22. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between AWX and USPH?

These companies operate in different sectors (AWX (Industrials) and USPH (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: AWX is a small-cap quality compounder stock; USPH is a small-cap high-growth stock. USPH pays a dividend while AWX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

AWX

Quality Business

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 5%
Run This Screen
Stocks Like

USPH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 13%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform AWX and USPH on the metrics below

Revenue Growth>
%
(AWX: 9.9% · USPH: 7.7%)
P/E Ratio<
x
(AWX: 30.7x · USPH: 41.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.